Ratnikova 1991.

Methods	Interventional study, exact methods are unclear
Participants	66 participants with recurrent erysipelas, probably from Russia
Interventions	Study groups: "conventional treatment" with bemitil 0.25 g/day to 0.5 g/day by mouth for 5 to 7 days "placebo"
Outcomes	Not reported
Notes	Only abstract was available The bemitil group was free of intoxication symptoms and local manifestations and discharged from hospital sooner than the controls The investigator considers bemitil as an immunostimulator that promotes activation of mononuclear phagocytes